Mark Toshner
Overview
Explore the profile of Mark Toshner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
7229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Samat A, Cassar M, Akhtar A, McCracken C, Ashkir Z, Mills R, et al.
Int J Cardiol
. 2024 Aug;
415:132415.
PMID: 39127146
Background: The role of ECG in ruling out myocardial complications on cardiac magnetic resonance (CMR) is unclear. We examined the clinical utility of ECG in screening for cardiac abnormalities on...
13.
Tackney M, Steele A, Newman J, Fritzsche M, Lucivero F, Khadjesari Z, et al.
Trials
. 2024 Aug;
25(1):521.
PMID: 39095915
Background: Digital technologies, such as wearable devices and smartphone applications (apps), can enable the decentralisation of clinical trials by measuring endpoints in people's chosen locations rather than in traditional clinical...
14.
Lasserson D, Gaddu P, Mehta S, Ignatowicz A, Greenfield S, Prince C, et al.
Health Technol Assess
. 2024 Jul;
:1-17.
PMID: 38970429
Research Question: Is withholding anticoagulation for patients with isolated or incidental subsegmental pulmonary embolism clinically and cost-effective compared with full anticoagulation for 3 months? Background: There has been an increase...
15.
Toshner M
Am J Respir Crit Care Med
. 2024 Jun;
210(9):1077-1078.
PMID: 38924495
No abstract available.
16.
Lawrie A, Chin K, Fong Y, Gargano C, Gitton X, He C, et al.
Pulm Circ
. 2024 Jun;
14(2):e12386.
PMID: 38868397
A blood test identifying patients at increased risk of pulmonary hypertension (PH) could streamline the investigative pathway. The prospective, multicenter CIPHER study aimed to develop a microRNA-based signature for detecting...
17.
Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, et al.
Pulm Circ
. 2024 Mar;
14(1):e12337.
PMID: 38500737
Approved therapies for the treatment of patients with pulmonary arterial hypertension (PAH) mediate pulmonary vascular vasodilatation by targeting distinct biological pathways. International guidelines recommend that patients with an inadequate response...
18.
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism
Liley J, Newnham M, Bleda M, Bunclark K, Auger W, Barbera J, et al.
Am J Respir Crit Care Med
. 2024 Mar;
209(12):1477-1485.
PMID: 38470220
Chronic thromboembolic pulmonary hypertension involves the formation and nonresolution of thrombus, dysregulated inflammation, angiogenesis, and the development of a small-vessel vasculopathy. We aimed to establish the genetic basis of chronic...
19.
Woolf B, Perry J, Hong C, Wilkins M, Toshner M, Gill D, et al.
Eur Respir J
. 2024 Mar;
63(4).
PMID: 38453257
No abstract available.
20.
Newman J, Wild P, Summers C, Toshner M
Trials
. 2024 Jan;
25(1):90.
PMID: 38281039
Background: The NIHR's Associate Principal Investigator (API) Scheme in the United Kingdom was expanded nationally in 2020 with the aim of training clinicians to become Principal Investigators for clinical research...